Notify me when Ikarian Capital, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 135 | $768,745,581 | +$360,398,710 | -$192,365,636 | +$168,033,074 | TERN, CDTX, ABVX, JAZZ, MAZE | 13F-HR | 17 Feb 2026, 18:46 |
| Q3 2025 | 116 | $439,984,294 | +$254,706,650 | -$208,675,229 | +$46,031,421 | ABVX, IONS, CDTX, MAZE, PTCT | 13F-HR | 14 Nov 2025, 16:10 |
| Q2 2025 | 103 | $300,829,656 | +$100,661,090 | -$115,783,943 | -$15,122,853 | CDTX, ALNY, INSM, VRNA, CRNX | 13F-HR | 14 Aug 2025, 16:26 |
| Q1 2025 | 116 | $306,936,404 | +$113,906,135 | -$94,445,896 | +$19,460,239 | TARS, CRNX, SPY, SRPT, BPMC | 13F-HR | 15 May 2025, 16:11 |
| Q4 2024 | 122 | $350,200,332 | +$129,919,133 | -$100,191,056 | +$29,728,077 | TARS, CRNX, SRRK, BPMC, FBRX | 13F-HR | 14 Feb 2025, 16:13 |
| Q3 2024 | 96 | $316,998,321 | +$113,639,080 | -$124,560,806 | -$10,921,726 | TARS, CRNX, ELVN, RCUS, VRDN | 13F-HR | 14 Nov 2024, 16:14 |
| Q2 2024 | 85 | $317,178,318 | +$89,477,907 | -$75,171,819 | +$14,306,088 | SRPT, CRNX, TARS, SLNO, CRBP | 13F-HR | 14 Aug 2024, 16:13 |
| Q1 2024 | 82 | $367,665,481 | +$129,849,305 | -$202,506,980 | -$72,657,675 | CRNX, TARS, SLNO, CRBP, SRPT | Restatement | 16 May 2024, 19:00 |
| Q4 2023 | 78 | $365,293,990 | +$163,164,141 | -$109,212,928 | +$53,951,213 | ARGX, CRNX, SLNO, XHB, BBIO | 13F-HR | 14 Feb 2024, 16:28 |
| Q3 2023 | 81 | $268,942,888 | $0 | $0 | $0 | SLRN, CRNX, SLNO, RCKT, NUVL | 13F-HR | 14 Nov 2023, 16:19 |
| Q2 2023 | 81 | $282,804,990 | +$162,938,587 | -$111,555,376 | +$51,383,211 | SLRN, APLS, MRK, IDYA, NUVL | 13F-HR | 14 Aug 2023, 08:46 |
| Q1 2023 | 90 | $239,302,817 | +$107,416,874 | -$84,327,948 | +$23,088,926 | RXDX, IMVT, ATXS, MRK, BBIO | 13F-HR | 15 May 2023, 09:57 |
| Q4 2022 | 66 | $240,835,239 | +$64,022,452 | -$65,652,621 | -$1,630,169 | RXDX, IMVT, PCVX, CLDX, ESPR | 13F-HR | 14 Feb 2023, 16:26 |
| Q3 2022 | 64 | $199,718,000 | +$90,673,462 | -$154,883,806 | -$64,210,344 | ISEE, ESPR, RXDX, DCPH, BLU | 13F-HR | 14 Nov 2022, 16:05 |
| Q2 2022 | 97 | $237,652,000 | +$90,078,657 | -$130,708,511 | -$40,629,854 | CLDX, ESPR, HZNP, KRTX, KZR | 13F-HR | 12 Aug 2022, 16:24 |
| Q1 2022 | 155 | $326,685,000 | +$88,425,885 | -$48,804,377 | +$39,621,508 | BCYC, CLDX, KZR, MIST, HZNP | 13F-HR | 13 May 2022, 16:05 |
| Q4 2021 | 149 | $347,784,000 | +$78,669,013 | -$121,386,292 | -$42,717,279 | BCYC, KZR, CLDX, ZNTL, GOSS | 13F-HR | 14 Feb 2022, 09:46 |
| Q3 2021 | 144 | $427,821,000 | +$122,733,910 | -$202,559,697 | -$79,825,787 | BCYC, GOSS, CLDX, CABA, XFOR | 13F-HR | 15 Nov 2021, 08:41 |
| Q2 2021 | 153 | $555,608,000 | +$154,658,372 | -$246,928,017 | -$92,269,645 | BIIB, CRSP, XFOR, TCON, ALEC | Restatement | 18 Aug 2021, 13:39 |
| Q1 2021 | 178 | $667,596,000 | +$308,422,032 | -$223,871,319 | +$84,550,713 | LLY, XFOR, TCON, MGNX, GLPG | Restatement | 18 Aug 2021, 13:35 |
| Q4 2020 | 133 | $544,306,000 | +$231,607,439 | -$129,363,136 | +$102,244,303 | TCON, CLDX, KALV, BMY, MORF | 13F-HR | 12 Feb 2021, 15:57 |
| Q3 2020 | 102 | $358,363,000 | +$182,738,677 | -$131,899,343 | +$50,839,334 | CLDX, KALV, OCUL, MIST, TARA | 13F-HR | 16 Nov 2020, 09:26 |
| Q2 2020 | 87 | $328,885,000 | +$138,054,050 | -$170,389,104 | -$32,335,054 | CLDX, OCUL, BPMC, TARA, BTAI | 13F-HR | 14 Aug 2020, 09:20 |
| Q1 2020 | 73 | $266,519,000 | +$205,232,660 | -$31,810,084 | +$173,422,576 | XLRN, BTAI, VSTM, ZGNX, IMVT | 13F-HR | 15 May 2020, 08:22 |
| Q4 2019 | 53 | $106,550,000 | $0 | $0 | $0 | AUPH, SAGE, IMVT, APTOSE BIOSCIENCES INC, CHMA | 13F-HR | 31 Jan 2020, 10:13 |